Head and neck cancers rank as the seventh most common type of cancer globally, significantly impacting smokers, drinkers, and individuals with HPV infections. Cisplatin, a standard chemotherapy drug, coupled with radiation therapy, remains the gold standard for treating these cancers. However, over
Women in early postmenopause often face the decision of whether to undergo menopausal hormone therapy (MHT) to manage their symptoms, and concerns over potential cognitive side effects can impact this choice considerably. Recently published research by Carey Gleason and colleagues from the
Rare diseases, though individually uncommon, collectively impact millions of people worldwide. Most of these conditions manifest in childhood, with genetic factors being the primary cause in about 80% of cases. Children with rare genetic disorders often endure prolonged diagnostic journeys
The pharmaceutical industry stands on the precipice of a monumental shift, driven by the rapid progress in artificial intelligence (AI). By 2025, AI is expected to significantly transform drug development processes, making them more efficient, accurate, and personalized. This article delves into
Glioblastoma, one of the most aggressive and lethal forms of brain cancer, presents a significant challenge to medical professionals due to its resistance to standard therapies. The complexity of its cellular structure and its ability to evade the immune system make it particularly difficult to
Recent research has uncovered a startling discovery: certain rare genetic mutations in the breast cells of healthy women may be early indicators of breast cancer development. This groundbreaking study, conducted by researchers from the University of British Columbia (UBC), BC Cancer, Harvard
